Jim Phillips, chief executive at Midatech Pharma Plc (LONMTPH, NASDAQ:MTP), updates Proactive's Andrew Scott on their three high-value, lead programmes progressing through pre-clinical and clinical development.
The key to each of those programmes is Midatech's technology which allows it to precisely deploy drugs into the body.
Its two platforms - carbohydrate-coated gold nano-particles and its sustained release system - are about getting medicines to the right place in the right quantities at the right time.
Last month they secured a US$15mln, four-year senior loan facility to help bankroll the programmes.
Meet Anglo Asian Mining Plc, Condor Gold PLC, Connemara Mining and Papua Mining PLC at our event, London, 08 February 2018.Register here >>